None listed
Conditions
Interventions
Experimental Group (Group S):The patient underwent left and right TAP blocks preoperatively, with 15 ml of liposomal bupivacaine solution administered on each side.
Control group (Group C):The patient underwent bilateral serratus anterior block before surgery, with 15 ml of liposomal bupivacaine solution administered on each side.
Sponsors
The Second Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Planned laparoscopic cholecystectomy with postoperative analgesia not using PCIA 2) American Society of Anesthesiologists (ASA) physical status classification I–III 3) BMI 18.5-28.5 4) Age >=18 years and <65 years 5) Voluntary participation and able to understand and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1) History of previous abdominal open surgery 2) Concurrent neuromuscular diseases leading to decreased abdominal muscle tone 3) Patients with cognitive impairment or difficulty communicating 4) Malignant tumors causing cachexia or massive ascites 5) Severe lesions in other systems (e.g., severe ventilatory dysfunction in COPD, cor pulmonale, multi-vessel coronary artery disease in patients with coronary heart disease, liver or kidney failure, etc.) 6) History of neurological disorders, such as stroke, traumatic brain injury, spinal cord injury, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative vomiting incidence;Nausea NRS score;Proportion of internal oblique muscle thickening; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain Intensity (Visual Analog Scale, VAS); | — |
Countries
China
Contacts
Public ContactDuan Guangyou
The Second Affiliated Hospital of Chongqing Medical University
Outcome results
None listed